Galmed Pharmaceuticals Ltd 携手Barcode Nanotech开发可穿透血脑屏障的Aramchol新制剂

美股速递
Apr 09

Galmed Pharmaceuticals Ltd宣布与Barcode Nanotech合作,成功研发出一种能够突破血脑屏障的Aramchol新型制剂。这项突破性技术有望为中枢神经系统疾病的治疗开辟新途径。

通过纳米技术的精准操控,该制剂可有效提升药物在脑部的分布浓度,为神经退行性疾病及代谢紊乱相关脑部病变的干预提供全新解决方案。此次技术突破标志着Aramchol在临床应用范围上的重要拓展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10